Clinical trials
Phase 1/2 trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 9 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 10 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 24 |
| Active, not recruiting | 8 |
| Terminated | 6 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 28 |
| Bristol-Myers Squibb | 10 |
| Sanofi | 5 |
| Daiichi Sankyo | 2 |
| MedImmune LLC | 2 |
| Pontificia Universidad Catolica de Chile | 2 |
| University of Chile | 2 |
| Agenus Inc. | 1 |
| Algenis SpA | 1 |
| Alnylam Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 4 |
| Carcinoma, Transitional Cell | 4 |
| Esophageal Neoplasms | 4 |
| Esophageal Squamous Cell Carcinoma | 4 |
| Melanoma | 4 |
| Neoplasm Metastasis | 4 |
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| COVID-19 | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.